2025年虚拟活体组织切片全球市场报告

预计未来几年虚拟活体组织切片市场规模将快速成长。到2029年，该市场规模将成长至11.2亿美元，年复合成长率（CAGR）为12.0%。预测期内的预期增长受诸多因素驱动，例如对经济高效的医疗保健解决方案的日益关注、对预防医学的重视、对个性化医疗日益增长的需求、对微创癌症治疗日益增长的兴趣以及精准肿瘤学日益增长的重要性。预测期内的主要趋势包括先进成像感测器的发展、多模态切片检查技术的演进、与机器人技术的整合以提高准确性、非侵入性生物标记检测的创新以及3D(3D) 可视化工具的采用。

预计肿瘤疾病盛行率的不断上升将在未来几年显着推动虚拟活体组织切片市场的成长。肿瘤疾病是指与癌症相关的健康状况，其特征是体内细胞异常增生和扩散。癌症患者数量的增加主要归因于不良饮食、缺乏运动、吸烟以及进一步接触环境污染物等生活方式因素。虚拟活体组织切片透过提供非侵入性即时影像解决方案来支援这些疾病的诊断和监测，该解决方案最大限度地减少了对传统组织切片检查的需求，同时提高了诊断的准确性和病患安全性。例如，2024 年 7 月，澳洲健康与福利研究所报告称，澳洲的癌症诊断数量从 2021 年的 156,781 例增加到 2022 年的 160,570 例，增加了 3,789 例。因此，肿瘤疾病盛行率的不断上升正在刺激虚拟活体组织切片市场的扩张。

虚拟活体组织切片市场的关键参与者正在优先开发和获得磁振造影波谱 (MRS) 平台等先进技术的监管批准，以提高非侵入性诊断的准确性并支援早期疾病核准和个人化医疗。 MRS 是一种非侵入性影像方法，它透过提供组织的详细分子资讯来帮助虚拟活体组织切片，从而实现即时疾病监测并无需手术。例如，2023 年 11 月，美国健康科技公司 BrainSpec Inc. 获得了美国食品药物管理局(FDA) 对其 AI 驱动的 BrainSpec 平台的核准。该平台使用人工智慧分析 MR 波谱数据以检测 2-羟基戊二酸等脑代谢物，从而实现非侵入性虚拟切片检查，以诊断神经胶质瘤、阿兹海默症和多发性硬化症。该系统与标准 MRI 扫描仪集成，可自动进行数据分析，在几分钟内提供结果，并依靠脑化学参考资料资料库来提高诊断信心。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球虚拟活体组织切片PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球虚拟活体组织切片市场：成长率分析
• 全球虚拟活体组织切片市场表现：规模与成长，2019-2024
• 全球虚拟活体组织切片市场预测：规模与成长，2024-2029 年，2034 年
• 全球虚拟活体组织切片总目标市场（TAM）

第六章市场区隔

• 全球虚拟活体组织切片市场依治疗领域、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 肿瘤疾病
• 神经系统疾病
• 心血管疾病
• 眼科疾病
• 内分泌失调
• 胃肠道疾病
• 其他目标治疗领域
• 全球癌症虚拟活体组织切片市场现况及预测（2019-2024 年、2024-2029 年及 2034 年）
• 固态恶性肿瘤
• 乳癌
• 肺癌
• 摄护腺癌
• 大肠直肠癌
• 脑肿瘤
• 其他癌症标靶
• 全球虚拟活体组织切片市场影像技术现况及预测，2019-2024 年、2024-2029 年、2034 年
• 磁振造影
• 电脑断层扫描
• X射线
• 超音波
• 其他成像技术
• 全球虚拟活体组织切片市场：按最终用户、业绩和预测，2019-2024 年、2024-2029 年、2034 年
• 医院和诊所
• 研究机构和诊断中心
• 其他最终用户
• 全球虚拟活体组织切片市场按肿瘤疾病类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
• 肺癌
• 乳癌
• 摄护腺癌
• 大肠直肠癌
• 肝癌
• 脑肿瘤
• 其他癌症
• 全球虚拟活体组织切片市场细分（按神经系统疾病类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
• 阿兹海默症
• 帕金森氏症
• 多发性硬化症
• 癫痫
• 脑损伤
• 中风
• 其他神经系统疾病
• 全球虚拟活体组织切片市场，依心血管疾病类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 冠状动脉疾病
• 心臟衰竭
• 心律不整
• 主动脉瘤
• 心臟瓣膜疾病
• 心肌梗塞
• 其他心血管疾病
• 全球虚拟活体组织切片市场细分（按眼科疾病类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
• 老龄化黄斑部病变
• 糖尿病视网膜病变
• 青光眼
• 视网膜静脉阻塞
• 白内障
• 其他眼科疾病
• 全球虚拟活体组织切片市场按内分泌疾病类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
• 糖尿病
• 甲状腺疾病
• 肾上腺疾病
• 脑下垂体疾病
• 副甲状腺疾病
• 其他内分泌疾病
• 全球虚拟活体组织切片市场按胃肠道疾病类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
• 发炎性肠道疾病
• 结肠息肉
• 胃溃疡
• 肝硬化
• 胰臟疾病
• 肝炎
• 其他胃肠道疾病
• 全球虚拟活体组织切片市场其他目标治疗领域细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 肌肉骨骼疾病
• 肾臟疾病
• 肺部疾病
• 血液系统疾病
• 皮肤病
• 感染疾病
• 其他条款

第七章 区域和国家分析

• 全球虚拟活体组织切片市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球虚拟活体组织切片市场：按国家/地区、业绩和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 虚拟活体组织切片市场：竞争格局
• 虚拟活体组织切片市场：公司简介
  • Canon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Hologic Inc.
• Illumina Inc.
• Guardant Health Inc.
• Esaote SpA
• Samsung Medison Co Ltd.
• Telix Pharmaceuticals Limited
• Freenome Holdings Inc.
• Perspectum Ltd.
• QUIBIM SL
• IQ-AI Limited
• BrainSpec Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年虚拟活体组织切片市场：提供新机会的国家
• 2029年虚拟活体组织切片市场：细分市场带来新机会
• 2029年虚拟活体组织切片市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Virtual biopsy is a non-invasive diagnostic method that leverages advanced imaging technologies and computer algorithms to analyze tissues for signs of disease. Its primary goal is to identify abnormalities, such as tumors or infections, without the need for traditional tissue sampling, minimizing risks and recovery time for patients. This technique is safer, faster, and less painful compared to conventional biopsies.

The main therapeutic areas targeted by virtual biopsy include oncology, neurology, cardiology, ophthalmology, endocrinology, gastroenterology, and other related conditions. Oncological disorders involve diseases characterized by the uncontrolled growth and spread of abnormal cells, commonly known as cancer, which can affect various organs and tissues. Virtual biopsy is used for detecting a wide range of cancers, including solid tumors, breast cancer, lung cancer, prostate cancer, colorectal cancer, brain cancer, and others. The imaging technologies utilized in virtual biopsy include magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound, among others, and are employed by end users such as hospitals, clinics, research institutes, diagnostic centers, and more.

The virtual biopsy market research report is one of a series of new reports from The Business Research Company that provides virtual biopsy market statistics, including the virtual biopsy industry's global market size, regional shares, competitors with the virtual biopsy market share, detailed virtual biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the virtual biopsy market. This virtual biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The virtual biopsy market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.71 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth observed during the historic period can be attributed to the increasing demand for non-invasive diagnostic techniques, a growing preference for early disease detection, enhanced efficiency in medical imaging software, greater patient convenience and comfort, and the expanding availability of telemedicine services.

The virtual biopsy market size is expected to see rapid growth in the next few years. It will grow to $1.12 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The expected growth in the forecast period is driven by factors such as a greater focus on cost-effective healthcare solutions, an emphasis on preventive healthcare, increasing demand for personalized medicine, rising interest in minimally invasive cancer treatments, and the growing significance of precision oncology. Key trends in the forecast period include the development of advanced imaging sensors, the evolution of multimodal biopsy techniques, integration with robotics for enhanced precision, innovations in non-invasive biomarker detection, and the incorporation of three-dimensional (3D) visualization tools.

The increasing prevalence of oncological disorders is anticipated to significantly drive the growth of the virtual biopsy market in the coming years. Oncological disorders refer to cancer-related health conditions characterized by the abnormal growth and spread of cells within the body. This rise in cancer cases is largely attributed to lifestyle factors such as poor dietary habits, physical inactivity, tobacco consumption, and greater exposure to environmental pollutants. Virtual biopsy supports the diagnosis and monitoring of these disorders by offering non-invasive, real-time imaging solutions that minimize the need for traditional tissue biopsies while enhancing diagnostic precision and patient safety. For example, in July 2024, the Australian Institute of Health and Welfare reported that cancer diagnoses in Australia increased to 160,570 in 2022, up from 156,781 in 2021-an increase of 3,789 cases. As a result, the growing incidence of oncological disorders is fueling the expansion of the virtual biopsy market.

Key players in the virtual biopsy market are prioritizing the development of advanced technologies and regulatory approvals, such as magnetic resonance spectroscopy (MRS) platforms, to improve the accuracy of non-invasive diagnostics and support early disease detection and personalized care. MRS is a non-invasive imaging method that assists virtual biopsy by delivering detailed molecular information of tissues, enabling real-time disease monitoring and eliminating the need for surgical procedures. For instance, in November 2023, BrainSpec Inc., a U.S.-based healthtech company, received approval from the U.S. Food and Drug Administration (FDA) for its AI-powered BrainSpec platform. This platform analyzes MR spectroscopy data using artificial intelligence to detect brain metabolites such as 2-hydroxyglutarate, enabling non-invasive virtual biopsies for diagnosing gliomas, Alzheimer's disease, and multiple sclerosis. The system integrates with standard MRI scanners, automates data analysis, delivers results within minutes, and relies on a reference database of brain chemistry to improve diagnostic reliability.

In July 2022, Quibim S.L., a healthtech firm based in Spain, entered a partnership with Microsoft Corporation to develop artificial intelligence-powered virtual biopsy tools. This collaboration seeks to advance non-invasive diagnostic capabilities by merging Quibim's AI-based imaging solutions with Microsoft's Azure cloud infrastructure. The goal is to enhance disease detection accuracy and minimize dependence on conventional biopsy techniques. Microsoft Corporation, headquartered in the U.S., is a globally recognized technology company known for its software products and digital services.

Major players in the virtual biopsy market are Canon Inc., Siemens Healthineers AG, GE Healthcare, Quest Diagnostics Incorporated, Olympus Corporation, Hologic Inc., Illumina Inc., Guardant Health Inc., Esaote S.p.A, Samsung Medison Co. Ltd., Telix Pharmaceuticals Limited, Freenome Holdings Inc., Perspectum Ltd., QUIBIM S.L, IQ-AI Limited, BrainSpec Inc., Oncoustics Inc., ImageBiopsy Lab GmbH, AI Metrics LLC, and Deep Bio Inc.

North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in virtual biopsy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the virtual biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The virtual biopsy market consists of revenues earned by entities by providing services such as imaging diagnostics, artificial intelligence (AI)-based interpretation, biomarker testing, telemedicine services, and three-dimensional (3D) tissue modeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The virtual biopsy market also includes sales of biopsy needle systems, artificial intelligence (AI)-based diagnostic tools, endoscopic systems, and photoacoustic imaging devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Virtual Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on virtual biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for virtual biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The virtual biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Target Thrapeutic Areas: Oncological Disorders; Neurological Disorders; Cardiovascular Disorders; Ophthalmological Disorders; Endocrine Disorders; Gastrointestinal Disorders; Other Target Therapeutic Areas
• 2) By Cancer Targeted: Solid Malignancies; Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Cancer; Other Cancer Targeteds
• 3) By Imaging Technologies: Magnetic Resonance Imaging; Computed Tomography; X-Ray; Ultrasound; Other Imaging Technologies
• 4) By End Users: Hospitals And Clinics; Research Institutes And Diagnostic Centers; Other End Users
• Subsegments:
• 1) By Oncological Disorders: Lung Cancer; Breast Cancer; Prostate Cancer; Colorectal Cancer; Liver Cancer; Brain Tumors; Other Cancers
• 2) By Neurological Disorders: Alzheimer's Disease; Parkinson's Disease; Multiple Sclerosis; Epilepsy; Brain Injuries; Stroke; Other Neurological Conditions
• 3) By Cardiovascular Disorders: Coronary Artery Disease; Heart Failure; Arrhythmias; Aortic Aneurysm; Valvular Heart Disease; Myocardial Infarction; Other Cardiovascular Conditions
• 4) By Ophthalmological Disorders: Age-Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Retinal Vein Occlusion; Cataracts; Other Eye Disorders
• 5) By Endocrine Disorders: Diabetes Mellitus; Thyroid Disorders; Adrenal Gland Disorders; Pituitary Gland Disorders; Parathyroid Disorders; Other Endocrine Conditions
• 6) By Gastrointestinal Disorders: Inflammatory Bowel Disease; Colorectal Polyps; Gastric Ulcers; Liver Cirrhosis; Pancreatic Disorders; Hepatitis; Other Gastrointestinal Conditions
• 7) By Other Target Therapeutic Areas: Musculoskeletal Disorders; Renal Disorders; Pulmonary Disorders; Hematologic Disorders; Dermatological Disorders; Infectious Diseases; Other Miscellaneous Conditions
• Companies Mentioned: Canon Inc.; Siemens Healthineers AG; GE Healthcare; Quest Diagnostics Incorporated; Olympus Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Virtual Biopsy Market Characteristics

3. Virtual Biopsy Market Trends And Strategies

4. Virtual Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Virtual Biopsy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Virtual Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Virtual Biopsy Market Growth Rate Analysis
• 5.4. Global Virtual Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Virtual Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Virtual Biopsy Total Addressable Market (TAM)

6. Virtual Biopsy Market Segmentation

• 6.1. Global Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncological Disorders
• Neurological Disorders
• Cardiovascular Disorders
• Ophthalmological Disorders
• Endocrine Disorders
• Gastrointestinal Disorders
• Other Target Therapeutic Areas
• 6.2. Global Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid Malignancies
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Cancer
• Other Cancer Targeteds
• 6.3. Global Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnetic Resonance Imaging
• Computed Tomography
• X-Ray
• Ultrasound
• Other Imaging Technologies
• 6.4. Global Virtual Biopsy Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Research Institutes And Diagnostic Centers
• Other End Users
• 6.5. Global Virtual Biopsy Market, Sub-Segmentation Of Oncological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Colorectal Cancer
• Liver Cancer
• Brain Tumors
• Other Cancers
• 6.6. Global Virtual Biopsy Market, Sub-Segmentation Of Neurological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alzheimer's Disease
• Parkinson's Disease
• Multiple Sclerosis
• Epilepsy
• Brain Injuries
• Stroke
• Other Neurological Conditions
• 6.7. Global Virtual Biopsy Market, Sub-Segmentation Of Cardiovascular Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coronary Artery Disease
• Heart Failure
• Arrhythmias
• Aortic Aneurysm
• Valvular Heart Disease
• Myocardial Infarction
• Other Cardiovascular Conditions
• 6.8. Global Virtual Biopsy Market, Sub-Segmentation Of Ophthalmological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Age-Related Macular Degeneration
• Diabetic Retinopathy
• Glaucoma
• Retinal Vein Occlusion
• Cataracts
• Other Eye Disorders
• 6.9. Global Virtual Biopsy Market, Sub-Segmentation Of Endocrine Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diabetes Mellitus
• Thyroid Disorders
• Adrenal Gland Disorders
• Pituitary Gland Disorders
• Parathyroid Disorders
• Other Endocrine Conditions
• 6.10. Global Virtual Biopsy Market, Sub-Segmentation Of Gastrointestinal Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inflammatory Bowel Disease
• Colorectal Polyps
• Gastric Ulcers
• Liver Cirrhosis
• Pancreatic Disorders
• Hepatitis
• Other Gastrointestinal Conditions
• 6.11. Global Virtual Biopsy Market, Sub-Segmentation Of Other Target Therapeutic Areas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Musculoskeletal Disorders
• Renal Disorders
• Pulmonary Disorders
• Hematologic Disorders
• Dermatological Disorders
• Infectious Diseases
• Other Miscellaneous Conditions

7. Virtual Biopsy Market Regional And Country Analysis

• 7.1. Global Virtual Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Virtual Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Virtual Biopsy Market

• 8.1. Asia-Pacific Virtual Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Virtual Biopsy Market

• 9.1. China Virtual Biopsy Market Overview
• 9.2. China Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Virtual Biopsy Market

• 10.1. India Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Virtual Biopsy Market

• 11.1. Japan Virtual Biopsy Market Overview
• 11.2. Japan Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Virtual Biopsy Market

• 12.1. Australia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Virtual Biopsy Market

• 13.1. Indonesia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Virtual Biopsy Market

• 14.1. South Korea Virtual Biopsy Market Overview
• 14.2. South Korea Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Virtual Biopsy Market

• 15.1. Western Europe Virtual Biopsy Market Overview
• 15.2. Western Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Virtual Biopsy Market

• 16.1. UK Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Virtual Biopsy Market

• 17.1. Germany Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Virtual Biopsy Market

• 18.1. France Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Virtual Biopsy Market

• 19.1. Italy Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Virtual Biopsy Market

• 20.1. Spain Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Virtual Biopsy Market

• 21.1. Eastern Europe Virtual Biopsy Market Overview
• 21.2. Eastern Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Virtual Biopsy Market

• 22.1. Russia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Virtual Biopsy Market

• 23.1. North America Virtual Biopsy Market Overview
• 23.2. North America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Virtual Biopsy Market

• 24.1. USA Virtual Biopsy Market Overview
• 24.2. USA Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Virtual Biopsy Market

• 25.1. Canada Virtual Biopsy Market Overview
• 25.2. Canada Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Virtual Biopsy Market

• 26.1. South America Virtual Biopsy Market Overview
• 26.2. South America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Virtual Biopsy Market

• 27.1. Brazil Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Virtual Biopsy Market

• 28.1. Middle East Virtual Biopsy Market Overview
• 28.2. Middle East Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Virtual Biopsy Market

• 29.1. Africa Virtual Biopsy Market Overview
• 29.2. Africa Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Virtual Biopsy Market Competitive Landscape And Company Profiles

• 30.1. Virtual Biopsy Market Competitive Landscape
• 30.2. Virtual Biopsy Market Company Profiles
  • 30.2.1. Canon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Virtual Biopsy Market Other Major And Innovative Companies

• 31.1. Hologic Inc.
• 31.2. Illumina Inc.
• 31.3. Guardant Health Inc.
• 31.4. Esaote S.p.A
• 31.5. Samsung Medison Co Ltd.
• 31.6. Telix Pharmaceuticals Limited
• 31.7. Freenome Holdings Inc.
• 31.8. Perspectum Ltd.
• 31.9. QUIBIM S.L
• 31.10. IQ-AI Limited
• 31.11. BrainSpec Inc.

32. Global Virtual Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Virtual Biopsy Market

34. Recent Developments In The Virtual Biopsy Market

35. Virtual Biopsy Market High Potential Countries, Segments and Strategies

• 35.1 Virtual Biopsy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Virtual Biopsy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Virtual Biopsy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer